Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what discussions the Chemotherapy Clinical Reference Group has had on the use of bisphosphonates for the indication of preventing secondary breast cancer since July 2015.

NHS England has advised that the Chemotherapy Clinical Reference Group (CRG) discussed the use of bisphosphonates for the indication of preventing secondary breast cancer during a meeting held in September 2015. It was raised in the context of guidance being developed by the Breast Cancer Clinical Reference Group and whether, through the Chemotherapy CRG, NHS England could implement any policy to support the use of these drugs. It was confirmed that these drugs would need to be commissioned by clinical commissioning groups.